Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
Department of Neurology, Istanbul University Cerrahpaşa School of Medicine, Istanbul, Turkey.
Sleep Breath. 2020 Sep;24(3):1101-1106. doi: 10.1007/s11325-019-01984-3. Epub 2020 Feb 20.
To evaluate the effect of vitamin D on severity of restless legs syndrome in patients with idiopathic restless legs syndrome (RLS).
Patients with idiopathic RLS completed questionnaires including the International Restless Legs Severity Scale (IRLSS) and were evaluated for vitamin D deficiency. Patients with deficiency of vitamin D were treated with 50,000 units per week for 2 months. At the end of the 2 months, vitamin D levels were re-measured and disease severity was re-evaluated in patients who reached adequate vitamin D level. Subgroups of IRLSS questionnaire were also analyzed.
Of 35 patients enrolled, 21 (60%) had vitamin D deficiency and received vitamin D therapy. In 2 patients, vitamin D levels did not rise to sufficient levels with supplementation and these 2 patients were excluded from analysis. The remaining 19 patients showed vitamin D levels increased from 13.2 ± 4.0 to 42.8 ± 9.6 ng/mL while IRLSS improved from 24.9 ± 5.1 to 21.1 ± 2.9 points (p <0.001). Selected subscores of the IRLSS were also improved including symptom severity (p <0.001), impact on sleep (p <0.001), symptom measures (p =0.002), and disease impact measures (p <0.001). There were trends toward improvement in subscores of frequency (p =0.11) and mood (p =0.051).
The findings suggest that vitamin D levels should be evaluated in patients with RLS and if vitamin D deficiency is revealed, consideration should be given to replacement therapy.u.
评估维生素 D 对特发性不安腿综合征(RLS)患者 RLS 严重程度的影响。
特发性 RLS 患者完成包括国际不安腿严重程度量表(IRLSS)在内的问卷,并评估维生素 D 缺乏情况。维生素 D 缺乏的患者接受每周 50,000 单位治疗 2 个月。在 2 个月结束时,测量维生素 D 水平,如果患者达到足够的维生素 D 水平,则重新评估疾病严重程度。还分析了 IRLSS 问卷的亚组。
在纳入的 35 名患者中,21 名(60%)有维生素 D 缺乏症并接受了维生素 D 治疗。在 2 名患者中,补充剂并未使维生素 D 水平升高到足够水平,这 2 名患者被排除在分析之外。其余 19 名患者的维生素 D 水平从 13.2±4.0ng/ml 升高至 42.8±9.6ng/ml,而 IRLSS 从 24.9±5.1 分改善至 21.1±2.9 分(p<0.001)。IRLSS 的选定亚评分也得到改善,包括症状严重程度(p<0.001)、对睡眠的影响(p<0.001)、症状测量(p=0.002)和疾病影响测量(p<0.001)。在频率(p=0.11)和情绪(p=0.051)亚评分方面也有改善的趋势。
这些发现表明,应评估 RLS 患者的维生素 D 水平,如果发现维生素 D 缺乏,应考虑替代治疗。